The billionaire owner of Patagonia has given the company away to environmental causes in a bid to help fight the climate crisis.
Standing by the morals the sportswear and outdoors fashion brand has always aligned with, and in a move that is no doubt setting the standard when it comes to environmental corporate leadership, Patagonia founder Yvon Chouinard and his family are giving away the entire company valued at $3 billion to a uniquely-structured trust and non-profit.
The move is designed to put all of the company’s profits into saving the planet.
Previously, Patagonia had given away 1% of its sales each year, and 2018, it said it was in “business to save our home planet” – but now, reluctant billionaire Mr Chouinard has said he feels this is “not enough”.
“I never wanted to be a businessman,” Mr Chouinard explained.
ADVERTISEMENT
“I started as a craftsman, making climbing gear for my friends and myself, then got into apparel [but] as we began to witness the extent of global warming and ecological destruction, and our own contribution to it, Patagonia is committed to using our company to change the way business was done.
“If we could do the right thing while making enough to pay the bills, we could influence customers and other businesses, and maybe change the system along the way.”
ADVERTISEMENT
Patagonia founder gives away $3 billion company to environmental causes fighting climate crisis / Credit: Patagonia
Kicking off the next 50 years, Patagonia says it’s “going purpose” instead of “going public”.
All ownership has been transferred to two new entities – Patagonia Purpose Trust and the Holdfast Collective.
Most significantly, every dollar that is not reinvested back into Patagonia will be distributed as dividends to protect the planet.
ADVERTISEMENT
The Patagonia Purpose Trust now owns all the voting stock of the company, and exists to create a more permanent legal structure to “enshrine Patagonia’s purpose and values”, and will help ensure that there is never deviation from the intent of the founder.
It will facilitate what the company says it continues to do best – “demonstrate as a for-profit business that capitalism can work for the planet.”
Instead of “going public,” you could say we’re “going purpose.” Instead of extracting value from nature and transforming it into wealth for investors, we’ll use the wealth Patagonia creates to protect the source of all wealth.
The Holdfast Collective now owns all the non-voting stock, and will use every dollar received from Patagonia to “protect nature and biodiversity”, support thriving communities, and ultimately, work on tackling and preventing climate change.
Each year, profits that are not reinvested back into the business, will be distributed by Patagonia as a dividend to help fight the climate crisis.
Announcing the transfer of the company, Mr Chouinard: “It’s been a half-century since we began our experiment in responsible business, but if we have any hope of a thriving planet 50 years from now, it demands all of us doing all we can with the resources we have.
“As the business leader I never wanted to be, I am doing my part.
“Instead of extracting value from nature and transforming it into wealth, we are using the wealth Patagonia creates to protect the source.
“We’re making Earth our only shareholder – I am dead serious about saving this planet.”
Featured Image – Patagonia
News
New endometriosis pill helping hundreds of women with ‘debilitating’ condition to be made available on NHS
Emily Sergeant
A groundbreaking new pill to help women with a ‘debilitating’ condition is set to be made available on the NHS.
The new daily pill for endometriosis – which has been approved for use on the NHS in England by the National Institute for Health and Care Excellence (NICE) – is called linzagolix, and will be available for those who have had previous treatment for endometriosis, working to manage any symptoms they may be experiencing.
Around 1.5 million women in the UK are thought to be currently living with endometriosis.
Endometriosis can cause chronic pain, heavy periods, and extreme tiredness when tissue similar to the womb lining grows elsewhere in the body.
A new daily pill for endometriosis has been approved for use on the NHS, and could help over a thousand women in England every year manage the symptoms of the debilitating condition.
As mentioned, linzagolix will be available specifically for patients whose previous medical or surgical treatments for endometriosis have been unsuccessful, and will be given alongside ‘add-back’ hormone therapy – which involves using low-dose hormone replacement therapy (HRT) to prevent menopause-like symptoms and bone loss.
This is the second take-at-home treatment to be approved to treat endometriosis on the NHS, and it’s thought that more than 1,000 women will benefit.
In clinical trials, linzagolix was shown to be successful in reducing painful periods and non-menstrual pelvic pain, compared with placebo, hence why it has been approved on the NHS by NICE.
“This is welcome news for women with endometriosis who haven’t found relief from previous therapies or surgery,” commented Dr Sue Mann, who is the National Clinical Director in Women’s Health for NHS England.
“It’s another treatment option which will help women take control of their health and better manage the symptoms of this often painful and debilitating condition.
“This is a testament to our ongoing commitment to improving treatment, care and quality of life for women.”
Featured Image – Heute
News
Wigan woman jailed after hitting pedestrian in Fiat 500 while driving high on nitrous oxide ‘balloons’
Emily Sergeant
A young woman from Wigan has been handed jail time after hitting a pedestrian while driving high on nitrous oxide.
Louisa Tunstall was driving a white Fiat 500 towards the East Lancashire Road in Wigan at around 7pm on Friday 24 May 2024 – a time when traffic conditions were said to be ‘quiet’ – but Tunstall was under the influence of a now-banned drug, nitrous oxide, at the time of the incident, Greater Manchester Police (GMP) confirmed.
While driving under the influence, 19-year-old Tunstall veered to the left onto the pavement and collided with a 51-year-old woman pedestrian.
After striking the woman, the car then overturned and, in the process, caused serious life-changing injuries.
When questioned by police, Tunstall stated that she ‘took her eyes off the road’ to retrieve something in the footwell before knowing the car had flipped, but she also confirmed that she had just been out to purchase nitrous oxide to use that evening.
After obtaining witness accounts, investigating officers were able to track down nearby CCTV footable which showed Tunstall inhaling nitrous oxide through a balloon whilst driving, seconds before the collision occurred.
#JAILED | It's not a laughing matter when you get behind the wheel under the influence of drugs.
Now Louisa Tunstall has to spend over a year behind bars after inhaling nitrous oxide and causing serious injury in #Wigan last year.
— Greater Manchester Police (@gmpolice) May 14, 2025
Further investigation by GMP’s Forensic Vehicle Examination Unit examined the Fiat 500 and confirmed that no defects were found on the car to contribute towards the collision.
Still to this day, the victim says she is trying to recover from the injuries sustained to her leg that will prevent her from continuing life as she did before.
“The incident is still very raw when I think about it,” the victim explained in her impact statement released by GMP. “I become upset when I think at everything which has been taken away from me and the ongoing affect it has had and continues to have on my daily life.”
GMP says it’s seeing the use of nitrous oxide being a factor in incidents they attend increasing year on year.
Nitrous oxide, also known as ‘laughing gas’, is reported to produce euphoria, relaxation, dizziness, giggling or laughing fits, impaired judgement, and occasionally dissociation and hallucinations – which GMP says affects reaction time and and is ‘likely lead to impairment’ in driving performance, particularly when faced with an unexpected or hazardous situation.
Tunstall appeared at Bolton Crown Court this week, and has been sentenced to one year and eight months imprisonment for having possession of a Class C drug, driving under the influence of drugs, and causing serious injury by dangerous driving.
Alongside being jailed, she was also disqualified from driving for two years and eight months, and has been ordered to take an extended test when she is released.
Emily Sergeant -
15th September 2022 
